Review
doi: 10.1007/s12325-010-0038-1.
Epub 2010 Jun 4.
Castration-refractory prostate cancer: New drugs in the pipeline
Affiliations
- PMID: 20532721
- DOI: 10.1007/s12325-010-0038-1
Item in Clipboard
Review
Castration-refractory prostate cancer: New drugs in the pipeline
Adv Ther.
2010 May.
Abstract
The standard treatment for patients with castration-refractory prostate cancer (CRPC) is the combination docetaxel-prednisone, if the patient can support chemotherapy. Several new treatments have been tested in chemotherapy-naïve or docetaxel-pretreated patients with CRPC. Some of these treatments have shown activity in first-line and second-line treatment. In this review, an update is given of new treatment studies performed in patients with CRPC.
Similar articles
-
New drugs in prostate cancer.Curr Opin Urol. 2006 May;16(3):138-45. doi: 10.1097/01.mou.0000193390.69845.bb. Curr Opin Urol. 2006. PMID: 16679849 Review.
-
Endocrine treatment of prostate cancer.J Steroid Biochem Mol Biol. 2004 Nov;92(4):287-95. doi: 10.1016/j.jsbmb.2004.10.005. Epub 2004 Dec 31. J Steroid Biochem Mol Biol. 2004. PMID: 15663992 Review.
-
[New perspectives in the drug therapy of hormone-resistant prostate cancer].Vopr Onkol. 2010;56(6):645-53. Vopr Onkol. 2010. PMID: 21395118 Review. Russian. No abstract available.
-
Recent advances in second-line treatment of castration-resistant prostate cancer.Curr Opin Support Palliat Care. 2011 Sep;5(3):199-205. doi: 10.1097/SPC.0b013e32834903aa. Curr Opin Support Palliat Care. 2011. PMID: 21734586 Review.
-
Current and emerging treatments in the management of castration-resistant prostate cancer.Expert Rev Anticancer Ther. 2012 Jul;12(7):951-64. doi: 10.1586/era.12.59. Expert Rev Anticancer Ther. 2012. PMID: 22845410 Review.
Cited by
-
Chromosome rearrangement associated inactivation of tumour suppressor genes in prostate cancer.Am J Cancer Res. 2011;1(5):604-17. Epub 2011 Apr 15. Am J Cancer Res. 2011. PMID: 21994901 Free PMC article.
-
Cotargeting Polo-Like Kinase 1 and the Wnt/β-Catenin Signaling Pathway in Castration-Resistant Prostate Cancer.Mol Cell Biol. 2015 Dec;35(24):4185-98. doi: 10.1128/MCB.00825-15. Epub 2015 Oct 5. Mol Cell Biol. 2015. PMID: 26438599 Free PMC article.
-
Co-expression of RAGE and HMGB1 is associated with cancer progression and poor patient outcome of prostate cancer.Am J Cancer Res. 2014 Jul 16;4(4):369-77. eCollection 2014. Am J Cancer Res. 2014. PMID: 25057439 Free PMC article.
-
Withanolides from Aeroponically Grown Physalis peruviana and Their Selective Cytotoxicity to Prostate Cancer and Renal Carcinoma Cells.J Nat Prod. 2017 Jul 28;80(7):1981-1991. doi: 10.1021/acs.jnatprod.6b01129. Epub 2017 Jun 15. J Nat Prod. 2017. PMID: 28617598 Free PMC article.
-
An update on the changing indications for androgen deprivation therapy for prostate cancer.Prostate Cancer. 2011;2011:419174. doi: 10.1155/2011/419174. Epub 2011 Feb 7. Prostate Cancer. 2011. PMID: 22110986 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
